Selected article for: "large scale and prospective study"
Author: Ha, Seok Gyun; Oh, Kyung Jin; Ko, Kwang-Pil; Sun, Yong Han; Ryoo, Eell; Tchah, Hann; Jeon, In Sang; Kim, Hyo Jeong; Ahn, Jung Min; Cho, Hye-Kyung
Title: Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children
  • Document date: 2018_9_18
    • ID: yrbo0hdk_36
    Snippet: Most of macrolide-unresponsive MP pneumonia patients achieved defervescence within 48 hours with CST add-on or treatment changes to DXC, and LFX, and any side effects were not observed in the secondary treatment groups. However, the secondary treatments did not shorten the duration of fever or hospitalization compared to PMC treatment. A large-scale prospective study is needed to guide appropriate treatment in children with mycoplasma pneumonia......
    Document: Most of macrolide-unresponsive MP pneumonia patients achieved defervescence within 48 hours with CST add-on or treatment changes to DXC, and LFX, and any side effects were not observed in the secondary treatment groups. However, the secondary treatments did not shorten the duration of fever or hospitalization compared to PMC treatment. A large-scale prospective study is needed to guide appropriate treatment in children with mycoplasma pneumonia.

    Search related documents:
    Co phrase search for related documents
    • appropriate treatment and hospitalization fever: 1
    • appropriate treatment and hospitalization fever duration: 1
    • appropriate treatment and large scale: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • appropriate treatment and macrolide unresponsive: 1, 2
    • appropriate treatment and PMC treatment: 1
    • appropriate treatment and pneumonia patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • appropriate treatment and prospective study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • appropriate treatment and secondary treatment: 1, 2, 3, 4, 5, 6, 7
    • appropriate treatment and secondary treatment group: 1
    • appropriate treatment and treatment group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • hospitalization fever and large scale: 1
    • hospitalization fever and prospective study: 1, 2, 3, 4, 5, 6
    • hospitalization fever and secondary treatment: 1, 2
    • hospitalization fever and treatment group: 1, 2, 3
    • hospitalization fever duration and prospective study: 1, 2, 3
    • hospitalization fever duration and secondary treatment: 1
    • large scale and PMC treatment: 1
    • large scale and pneumonia patient: 1, 2, 3, 4
    • large scale and prospective study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63